102 related articles for article (PubMed ID: 7300129)
1. Hyperosmolality, acetate, and lactate: dilatory factors during peritoneal dialysis.
Miller FN; Nolph KD; Joshua IG; Wiegman DL; Harris PD; Andersen DB
Kidney Int; 1981 Sep; 20(3):397-402. PubMed ID: 7300129
[TBL] [Abstract][Full Text] [Related]
2. Vasoactive components of dialysis solution.
Zakaria el R; Patel AA; Li N; Matheson PJ; Garrison RN
Perit Dial Int; 2008; 28(3):283-95. PubMed ID: 18474922
[TBL] [Abstract][Full Text] [Related]
3. Generalized dilation of the visceral microvasculature by peritoneal dialysis solutions.
Zakaria el R; Spain DA; Harris PD; Garrison RN
Perit Dial Int; 2002; 22(5):593-601. PubMed ID: 12455570
[TBL] [Abstract][Full Text] [Related]
4. Microvascular and clinical effects of altered peritoneal dialysis solutions.
Miller FN; Nolph KD; Harris PD; Rubin J; Wiegman DL; Joshua IG; Twardowski ZJ; Ghods AJ
Kidney Int; 1979 Jun; 15(6):630-9. PubMed ID: 37363
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of peritoneal dialysis-induced microvascular vasodilation.
Zakaria el R; Althani A; Fawzi AA; Fituri OM
Adv Perit Dial; 2014; 30():98-109. PubMed ID: 25338430
[TBL] [Abstract][Full Text] [Related]
6. Hyperosmolality-mediated peritoneal microvascular vasodilation is linked to aquaporin function.
Zakaria el R; Althani A; Fawzi AA; Fituri OM
Adv Perit Dial; 2014; 30():63-74. PubMed ID: 25338424
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic effects of peritoneal dialysis solutions on the rat peritoneal membrane: role of acidity, buffer choice, glucose concentration, and glucose degradation products.
Mortier S; De Vriese AS; Van de Voorde J; Schaub TP; Passlick-Deetjen J; Lameire NH
J Am Soc Nephrol; 2002 Feb; 13(2):480-489. PubMed ID: 11805178
[TBL] [Abstract][Full Text] [Related]
8. Addition of a nitric oxide inhibitor to a more biocompatible peritoneal dialysis solution in a rat model of chronic renal failure.
de Graaff M; Vlijm A; Zweers MM; Coester AM; Vandemaele F; Struijk DG; Krediet RT
Adv Perit Dial; 2010; 26():7-11. PubMed ID: 21348371
[TBL] [Abstract][Full Text] [Related]
9. Direct peritoneal resuscitation from hemorrhagic shock: effect of time delay in therapy initiation.
Zakaria el R; Garrison RN; Kawabe T; Harris PD
J Trauma; 2005 Mar; 58(3):499-506; discussion 506-8. PubMed ID: 15761343
[TBL] [Abstract][Full Text] [Related]
10. BIOKID: randomized controlled trial comparing bicarbonate and lactate buffer in biocompatible peritoneal dialysis solutions in children [ISRCTN81137991].
Nau B; Schmitt CP; Almeida M; Arbeiter K; Ardissino G; Bonzel KE; Edefonti A; Fischbach M; Haluany K; Misselwitz J; Kemper MJ; Rönnholm K; Wygoda S; Schaefer F;
BMC Nephrol; 2004 Oct; 5():14. PubMed ID: 15485574
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of lactate and acetate on clinical peritoneal clearances.
Rubin J; Nolph KD; Arfaania D; Wiegman DL; Miller FN; Harris PD
Clin Nephrol; 1979 Oct; 12(4):145-7. PubMed ID: 509789
[TBL] [Abstract][Full Text] [Related]
12. A comparison between the effects of acetate and lactate in peritoneal dialysis solutions.
Rossen B; Ladefoged J
Scand J Urol Nephrol; 1982; 16(3):279-81. PubMed ID: 7163792
[TBL] [Abstract][Full Text] [Related]
13. [Intracellular pH changes induced by sclerosing agents in peritoneal fibroblasts].
Soria M; Arrieta J; Ugarte I; Moina I; Guerra M; Escanero J
Nefrologia; 2004; 24(2):158-66. PubMed ID: 15219091
[TBL] [Abstract][Full Text] [Related]
14. Peritoneal clearances with three types of commerically available peritoneal dialysis solutions. Effects of pH adjustment and intraperitoneal nitroprusside.
Nolph KD; Rubin J; Wiegman DL; Harris PD; Miller FN
Nephron; 1979; 24(1):34-40. PubMed ID: 40148
[TBL] [Abstract][Full Text] [Related]
15. [Measuring the thickness of the peritoneum as a dialysis membrane using various osmolar concentrations of dialysis fluid].
Korten G
Z Urol Nephrol; 1990 Aug; 83(8):459-63. PubMed ID: 2238886
[TBL] [Abstract][Full Text] [Related]
16. Disparity in osmolarity-induced vascular reactivity.
Zakaria el R; Hunt CM; Li N; Harris PD; Garrison RN
J Am Soc Nephrol; 2005 Oct; 16(10):2931-40. PubMed ID: 16079269
[TBL] [Abstract][Full Text] [Related]
17. Net ultrafiltration volume (nUFV) during IPD with acetate or lactate dialysis solutions.
Grzegorzewska AE; Uchman G
Adv Perit Dial; 1990; 6():19-22. PubMed ID: 1982806
[TBL] [Abstract][Full Text] [Related]
18. Acetate versus lactate in peritoneal dialysis solutions.
Pedersen FB; Ryttov N; Deleuran P; Dragsholt C; Kildeberg P
Nephron; 1985; 39(1):55-8. PubMed ID: 3969192
[TBL] [Abstract][Full Text] [Related]
19. Clinical peritoneal dialysis solutions modulate white blood cell-intestinal vascular endothelium interaction.
Campbell JE; Garrison RN; Zakaria el R
Am J Surg; 2006 Nov; 192(5):610-6. PubMed ID: 17071193
[TBL] [Abstract][Full Text] [Related]
20. Maximum ultrafiltration rates during peritoneal dialysis in rats.
Levin TN; Rigden LB; Nielsen LH; Moore HL; Twardowski ZJ; Khanna R; Nolph KD
Kidney Int; 1987 Mar; 31(3):731-5. PubMed ID: 3573538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
